title: Somatostatin treatment can induce extensive fibrosis in growth hormone-producing adenoma.
authors.affiliation: Department of Neurosurgery, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria. johannes.kerschbaumer@tirol-kliniken.at.
authors.forename: Johannes
authors.initials: J
authors.lastname: Kerschbaumer
authors.affiliation: Department of Neurosurgery, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria.
authors.forename: Daniel
authors.initials: D
authors.lastname: Pinggera
authors.affiliation: Department of Pathology, Innsbruck Medical University, Innsbruck, Austria.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Moser
authors.affiliation: Department of Nuclear medicine and Endocrinology, Paracelsus Medical University, Salzburg, Austria.
authors.forename: Andrea
authors.initials: A
authors.lastname: Hofmann
authors.affiliation: Department of Neurosurgery, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria.
authors.forename: Claudius
authors.initials: C
authors.lastname: Thomé
authors.affiliation: Department of Neurosurgery, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria.
authors.forename: Christian Franz
authors.initials: CF
authors.lastname: Freyschlag
mesh_terms: D000236:Adenoma / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D000328:Adult; D005355:Fibrosis / Q000209:etiology; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D008297:Male; D013004:Somatostatin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D013004:Somatostatin; D013006:Growth Hormone